Clinical Trial Update: Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin Versus Doxorubicine in Patients With Leiomyosarcoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing doxorubicin with trabectedin followed by trabectedin versus doxorubicine in leiomyosarcoma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma of the Uterus
• Uterine Leiomyosarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Trabectedin (trabectedin)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Uterine or Soft Tissue Leiomyosarcoma | Phase 3 | Status: COMPLETED